Finance

Lists
Why is CGTX down 3.06%?
Dive Deeper
CGTX:NASDAQ
Cognition Therapeutics Inc
$0.58
-3.06%
(-0.018) 1D
$0.58
-0.38% (-0.0022)
After hours
Closed: Nov 20, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGTX...
Open
$0.60
High
$0.60
Low
$0.56
Mkt. cap
55.42M
Avg. vol.
539.22K
Volume
665.42K
52-wk high
$1.81
52-wk low
$0.55
EPS
-$0.18
Beta
1.84
Shares outstanding
95.10M
No. of employees
14
Open
$0.60
High
$0.60
Low
$0.56
Mkt. cap
55.42M
Avg. vol.
539.22K
Volume
665.42K
52-wk high
$1.81
52-wk low
$0.55
EPS
-$0.18
Beta
1.84
Shares outstanding
95.10M
No. of employees
14
News stories
From web sources and news partners
About Cognition Therapeutics Inc
CEO-
Employees14
FoundedJan 1, 2007
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecogrx.com
Analyst ratings
Based on 2 analysts giving stock ratings to CGTX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CGTX in the last 3 months.
Highest
Current $0.58
$3.00 (+415.29%)
Average
$3.00 (+415.29%)
Lowest
$3.00 (+415.29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$3.00
+415.3%
11/19/2026
Unknown Analyst
B. Riley Securities
Buy
Initiated
$3.00
+415.3%
11/06/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$4.00
+587%
05/08/2026
William Wood
B. Riley Securities
Buy
Maintained
$3.00
+415.3%
11/21/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
11.15M
6.12M
5.10M
5.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.52M
2.70M
2.64M
2.25M
Operating expense
13.67M
8.82M
7.74M
7.38M
Total operating expenses
13.67M
8.82M
7.74M
7.38M
Operating income
-13.67M
-8.82M
-7.74M
-7.38M
Other non operating income
10.33M
4.25M
3.81M
3.23M
EBT including unusual items
-3.34M
-4.57M
-3.93M
-4.14M
EBT excluding unusual items
-3.34M
-4.57M
-3.93M
-4.14M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.34M
-4.57M
-3.93M
-4.14M
Net profit margin
-
-
-
-
Earnings per share
-0.02
-0.05
-0.04
-0.04
Interest and investment income
-
-
-
-
Interest expense
-5.00K
-5.00K
-3.00K
-1.00K
Net interest expenses
-5.00K
-5.00K
-3.00K
-1.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-13.66M
-8.81M
-7.73M
-7.37M
Gain or loss from assets sale
41.00K
5.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps